This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Helmholtz-Zentrum Fur Infektionsforschung Gmbh. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Cansu Kaya: Innovator in Metallo-Beta-Lactamase Inhibitors
Introduction
Cansu Kaya is a notable inventor based in Braunschweig, Germany. She has made significant contributions to the field of medicinal chemistry, particularly in the development of novel inhibitors for bacterial infections.
Latest Patents
Cansu Kaya holds a patent for "N-phenyl-3-mercaptopropanamide derivatives as metallo-beta-lactamase inhibitors for the treatment of bacterial infections." This invention relates to innovative inhibitors of metallo-β-lactamases, which are crucial in combating antibiotic resistance.
Career Highlights
Throughout her career, Cansu has worked with esteemed institutions such as Helmholtz-Zentrum für Infektionsforschung GmbH and Universität des Saarlandes. Her work has focused on advancing research in infectious diseases and developing effective treatments.
Collaborations
Cansu has collaborated with notable colleagues, including Thomas Wichelhaus and Anna K. Hirsch. These partnerships have enhanced her research and contributed to her success in the field.
Conclusion
Cansu Kaya's work in developing metallo-beta-lactamase inhibitors showcases her dedication to addressing critical health challenges. Her innovative approach and collaborations highlight her impact on the field of medicinal chemistry.